First Minister of Wales Carwyn Jones will open this year’s BioWales at the Vale of Glamorgan Hotel on March 17.
29 January, 2010
ChEMBLdb, an online database of information on the properties of drugs and drug-like small molecules and their targets, has launched with information on more than half a million compounds.
28 January, 2010
Companies to collaborate on an exclusive basis on Alizé Pharma's unacylated ghrelin (AZP-01) program for the treatment of type II diabetes.
26 January, 2010
'The Robot Scientist' first to complete experimentation cycle without human involvement.
25 January, 2010
The most common form of malignant brain cancer in adults, glioblastoma multiforme, is not a single disease but seems to be four distinct molecular subtypes, according to a study by the Cancer Genome Atlas Research Network.
22 January, 2010
Rexahn Pharmaceuticals announces that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
21 January, 2010
The study is designed to confirm safety profile, pharmacokinetics and immunological effects and explore the impact of CYT107 on HIV-specific T-cell responses.
14 January, 2010
Lowering triglyceride levels for at-risk patients: first patients enrolled in MARINE and ANCHOR Phase III clinical trials for AMR101.
12 January, 2010
Astex Therapeutics announced recently that AstraZeneca has selected a clinical candidate from the PKB inhibitor collaborative programme.
08 January, 2010
BioWales will return in 2010 to showcase the bioscience sector in Wales to an international, commercial and academic audience of 400 delegates with a brokerage event and exhibition and a conference covering hot topics such as stem cells.
05 January, 2010